Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Mal-PEG8-Val-Ala-PAB-Exatecan

Catalog No. T77855 Copy Product Info
🥰Excellent
Mal-PEG8-Val-Ala-PAB-Exatecan is an ADC linker-payload featuring a cathepsin B-cleavable Val-Ala linker and Exatecan. It is used for Nectin-4 targeted ADC development.

Mal-PEG8-Val-Ala-PAB-Exatecan

Copy Product Info
🥰Excellent
Catalog No. T77855

Mal-PEG8-Val-Ala-PAB-Exatecan is an ADC linker-payload featuring a cathepsin B-cleavable Val-Ala linker and Exatecan. It is used for Nectin-4 targeted ADC development.

Mal-PEG8-Val-Ala-PAB-Exatecan
Cas No. 2679821-39-5
Pack SizePriceUSA StockGlobal StockQuantity
5 mg$5508-10 weeks8-10 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Mal-PEG8-Val-Ala-PAB-Exatecan is an ADC linker-payload featuring a cathepsin B-cleavable Val-Ala linker and Exatecan. It is used for Nectin-4 targeted ADC development.
Targets&IC50
Topoisomerase I:0.97 μM
In vivo
In KPL-4 xenograft models, conjugates with Mal-PEG8-Val-Ala-PAB-Exatecan (1-10 mg/kg) induced durable tumor regression and prolonged survival[1].
Chemical Properties
Molecular Weight1329.42
FormulaC66H85FN8O20
Cas No.2679821-39-5
SmilesN(C(OCC1=CC=C(NC([C@@H](NC([C@@H](NC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCN2C(=O)C=CC2=O)=O)=O)[C@H](C)C)=O)C)=O)C=C1)=O)[C@@H]3C4=C5C(C=6N(C5)C(=O)C7=C(C6)[C@](CC)(O)C(=O)OC7)=NC=8C4=C(CC3)C(C)=C(F)C8
Storage & Solubility Information
Storagekeep away from moisture,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (60.18 mM), Sonication is recommmended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.7522 mL3.7610 mL7.5221 mL37.6104 mL
5 mM0.1504 mL0.7522 mL1.5044 mL7.5221 mL
10 mM0.0752 mL0.3761 mL0.7522 mL3.7610 mL
20 mM0.0376 mL0.1881 mL0.3761 mL1.8805 mL
50 mM0.0150 mL0.0752 mL0.1504 mL0.7522 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Mal-PEG8-Val-Ala-PAB-Exatecan | purchase Mal-PEG8-Val-Ala-PAB-Exatecan | Mal-PEG8-Val-Ala-PAB-Exatecan cost | order Mal-PEG8-Val-Ala-PAB-Exatecan | Mal-PEG8-Val-Ala-PAB-Exatecan chemical structure | Mal-PEG8-Val-Ala-PAB-Exatecan in vivo | Mal-PEG8-Val-Ala-PAB-Exatecan formula | Mal-PEG8-Val-Ala-PAB-Exatecan molecular weight